findmyKOL
Clinical trialNCT05701527RecruitingPhase 1Interventional

A Study of EBC-129 in Advanced Solid Tumours

SponsorEDDC (Experimental Drug Development Centre), A*STAR Research EntitiesEnrollment98Advanced Solid Tumours
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Venkateshan Srirangam Prativadibhayankara, MD

    EDDC (Experimental Drug Development Centre), A*STAR Research Entities

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Singapore
  • National Cancer Centre Singapore

    Singapore, South West, Singapore

    Ng Matthew
    Recruiting
  • National University Hospital - Medical Oncology

    Singapore, South West, Singapore

    Yong Wei Peng
    Recruiting
Taiwan
  • Taipei Veterans General Hospital

    Taipei, Taipei, Taiwan

    Not, yet, recruiting
United States
  • University of Colorado Hospital (uch) - University of Colorado Cancer Center (uccc) - Neuroendocrine Tumor Center

    Aurora, Colorado, United States

    Sunnie Kim
    Recruiting
  • Ut Md Anderson Cancer Center

    Houston, Texas, United States

    Meric-Bernstam Funda
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Apr 2023
Primary completion
24 Dec 2026
Completion
24 Dec 2026
Last update posted
5 Feb 2026
Registered enrollment
98
Registry id
NCT05701527

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.